Hetényi, A.; Szabó, E.; Imre, N.; Bhaumik, K.N.; Tököli, A.; Füzesi, T.; Hollandi, R.; Horvath, P.; Czibula, Á.; Monostori, É.;
et al. α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Pharmaceutics 2022, 14, 580.
https://doi.org/10.3390/pharmaceutics14030580
AMA Style
Hetényi A, Szabó E, Imre N, Bhaumik KN, Tököli A, Füzesi T, Hollandi R, Horvath P, Czibula Á, Monostori É,
et al. α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Pharmaceutics. 2022; 14(3):580.
https://doi.org/10.3390/pharmaceutics14030580
Chicago/Turabian Style
Hetényi, Anasztázia, Enikő Szabó, Norbert Imre, Kaushik Nath Bhaumik, Attila Tököli, Tamás Füzesi, Réka Hollandi, Peter Horvath, Ágnes Czibula, Éva Monostori,
and et al. 2022. "α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition" Pharmaceutics 14, no. 3: 580.
https://doi.org/10.3390/pharmaceutics14030580
APA Style
Hetényi, A., Szabó, E., Imre, N., Bhaumik, K. N., Tököli, A., Füzesi, T., Hollandi, R., Horvath, P., Czibula, Á., Monostori, É., Deli, M. A., & Martinek, T. A.
(2022). α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Pharmaceutics, 14(3), 580.
https://doi.org/10.3390/pharmaceutics14030580